Showing 221-230 of 1148 results for "".
Exploring Expanded Labeling for DBS for Parkinson's
https://practicalneurology.com/diseases-diagnoses/movement-disorders/exploring-expanded-labeling-for-dbs-for-parkinsons/30694/Expanded labeling is based on data showing an improvement in quality of life and longer-term data.Exploring Effects of Epilepsy on the Young and the Disadvantaged
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/exploring-effects-of-epilepsy-on-the-young-and-the-disadvantaged/30722/In-Focus: Headache and Migraine
https://practicalneurology.com/diseases-diagnoses/headache-pain/in-focus-headache-and-migraine/30360/Open Payments Update: Will More Data + More Errors = More Physician Peril?
https://practicalneurology.com/columns/practice-management/open-payments-update-will-more-data--more-errors-more-physician-peril/30554/An early look at samples from the full 2014 Open Payments records suggests that physicians must be ready to review their records before they go public.Diagnosis and Management of Orthostatic Hypotension in Individuals with Parkinson Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/diagnosis-and-management-of-orthostatic-hypotension-in-individuals-with-parkinson-disease/37651/Orthostatic hypotension—a common but underrecognized manifestation of Parkinson disease—may result in falls, syncope, and other complications.Physical and Cognitive Activity for Dementia
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/physical-and-cognitive-activity-for-dementia/31733/There is enough evidence of the neuroprotective effects of physical and cognitive activity to recommend these to patients.News
https://practicalneurology.com/columns/practice-management/news/30633/Pharmacology of Emerging Selective Sodium Channel Antagonists for the Treatment of Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/pharmacology-of-emerging-selective-sodium-channel-antagonists-for-the-treatment-of-epilepsy/39904/The development of isoform-selective sodium channel inhibitors that spare GABAergic interneuron function is in its early stages but holds promise as an exciting area of research.Movement Disorders Moment: Incorporating Lifestyle Medicine Into Parkinson Disease Care—Evidence and Guidance for Clinical Practice
https://practicalneurology.com/diseases-diagnoses/movement-disorders/movement-disorders-moment-incorporating-lifestyle-medicine-into-parkinson-disease-care-evidence-and-guidance-for-clinical-practice/32196/Lifestyle medicine strategies play an important role in managing Parkinson disease and empowering patients and their care partners.Reader Response to: Migraine and Other Neurologic Conditions in Retired NFL Players
https://practicalneurology.com/diseases-diagnoses/headache-pain/reader-response-to-migraine-and-other-neurologic-conditions-in-retired-nfl-players/30272/